The Genomics Research Centre investigates the genetic basis of disease. The research is focused on common chronic human disorders - for example migraine, high blood pressure and cancer- that have a significant genetic component.
The identification of genes involved in these disorders is being pursued to lead to better forms of diagnosis and more appropriate treatments. Hence studies from genes to therapies is being undertaken within the Genomics Research Centre.
Scientists within the Genomics Research Centre have expertise in gene mapping and the characterisation of gene dysfunction. They also have the ability to translate this information to both diagnostic and therapeutic outcomes, through, for example, DNA mutation testing and vaccine development. In addition, the Centre is aware of the important ethical and psychological issues associated with genetics and consequently researchers within the Centre are actively engaged in training Genetic Counsellors and Clinical Geneticists.
The Centre has strong and developing research linkages with practising clinicians in various medical fields, as genes are now known to play a significant role in many disease states. Our aim is to identify genes involved in disease susceptibility and development, so that better forms of counselling, diagnosis and treatment may be used to prevent or cure common genetic disorders.
Aims: The focus of the Genomics Research Centre is the study of the genetic basis of disease. Our aim is to identify genes involved in disease susceptibility and development. Specific aims are:
- To identify genes involved in common, complex human disorders.
- To define the molecular basis of gene dysfunction and how this relates to disease.
- To use this information and develop better forms of diagnosis for genetic and lifestyle counselling to aid in disease adaptation and prevention.
- To develop more appropriate treatments targeted to the specific genetic causes underlying individual forms of disease.
A special Thanksgiving Service took place last night, Wednesday (October 29), when Griffith honoured the 57 people who have bequeathed their bodies to the Body Donation Program over the past 12 months.
The launch of the newly named Compounds Australia begins a program of growth and diversification to boost its collection and enhance benefits for industry and research
Experiencing the life of a university student on the Gold Coast is the aim this week for 25 Indigenous high school students hoping to work in health.